Drug – bio-affecting and body treating compositions – Radionuclide or intended radionuclide containing; adjuvant... – Attached to lymphokine – cytokine – or other secreted growth...
Patent
1994-11-22
1996-12-31
Hollinden, Gary E.
Drug, bio-affecting and body treating compositions
Radionuclide or intended radionuclide containing; adjuvant...
Attached to lymphokine, cytokine, or other secreted growth...
424 149, 424 169, 424 934, 424 96, 4241301, 4241451, 436543, 436547, 435 71, 530380, A61K 5100, A61K 39395, A61K 3514, G01N 3353
Patent
active
055891543
ABSTRACT:
Methods for preventing or treating vascular hemorrhaging such as that incident to thrombolytic therapy, or characteristic of Alzheimer's and related diseases are provided. Such methods provide improved thrombolytic therapy to individuals who receive such therapy, and permit the diagnosis and treatment of diseases, such as Alzheimer's disease, that are characterized by the deposition of amyloid deposits.
REFERENCES:
patent: 5231000 (1993-07-01), Majocha
patent: 5270165 (1993-12-01), Van Nostrand
Akiyama, H. et al., "Thrombin Accumulation In The Brains Of Patients With Alzheimer's Disease," Neurosci. Lett. 146:152-154 (1992).
Akiyama, H. et al., "Prothrombin Activation In Brains Of Patients With Alzheimer's Disease," Neurobiol. Aging 15:S124 (1994).
Coria, F. et al., "Brain Amyloid In Normal Aging And Cerebral Amyloid Angiopathy Is Antigenically Related To Alzheimer's Disease .beta.-Protein," Amer. J. Pathol. 129:422-428 (1987).
Cunningham, D. D., "Regulation Of Neuronal Cells And Astrocytes By Protease Nexin-1 And Thrombin," Annl. N.Y. Acad. Sci. 674:228-236 (1992).
Glenner, G. G. et al., "Alzheimer's Disease: Initial Report Of The Prurification And Characterization Of A Novel Cerebrovascular Amyloid Protein," Biochem. Biophys. Res. Commun. 120:885-890 (1984).
Hoylaerts, M. et al., "Kinetics Of The Activation Of Plasminogen By Human Tissue Plasminogen Activator," J. Biol. Chem. 259:2912-2919 (1982).
Kang, J. et al., "The Precursor of Alzheimer's Disease Amyloid A4 Protein Resembles A Cell-Surface Receptor," Nature 325:733-736 (1987).
Kase, C. S. et al., "Intracranial Hemmorrhage After Use Of Tissue Plasminogen Activator For Coronary Thrombolysis," Annls. Intern. Med. 112:17-21 (1990).
Levy, E. et al., "Mutation Of The Alzheimer's Disease Amyloid Gene In Hereditary Cerebral Hemorrhage, Dutch Type," Science 248:1124-1126 (1990).
Masters, C. L. et al., "Amyloid Plaque Core Protein In Alzheimer's Disease And Down's Syndrome," Proc. Natl. Acad. Sci. (U.S.A.) 82:4245-4249 (1985).
Molinari, G. F. "Lobar Hemorrhages Where Do They Come From? How Do They Get There?" Stroke 24:523-526 (1993).
Nieuwenhuizen, W. et al., "The Influence Of Fibrin(Ogen) Fragments On The Kinetic Parameters Of The Tissue Type Plasminogen-Activator-Mediated Activation Of Different Forms Of Plasminogen," Eur. J. Biochem. 174:163-169 (1988).
Pendlebury, W. W. et al., "Intracerebral Hemorrhage Related To Cerebral Amyloid Angiopathy And t-PA Treatment," Annls. Neurol. 28:210-213 (1989).
Powers, J. M. et al., "An Immunoperoxidase Study Of Senile Cerebral Amyloidosis With Pathogenic Considerations," J. Neuropathol. Exper. Neurol. 40:592-612 (1981).
Prelli, F. et al., "Differences Between Vascular And Plaque Core Amyloid In Alzheimer's Disease," J. Neurochem. 51:648-651 (1988).
Rebeck, G. W. et al., "Apolipoprotein E And Its Receptor LRP In AD And Control Brain," Neurobiol. Aging 15:S117 (1994).
Robakis, N. K. et al., "Molecular Cloning And Characterization Of A cDNA Encoding The Cerebrovascular And Neuritic Plaque Amyloid Protein," Proc. Natl. Acad. (U.S.A.) 84:4190-4194 (1987).
Selkoe, D. J., "Physiological Production Of The .beta.-Amyloid Protein And The Mechanism Of Alzheimer's Disease," Neurobiol. Aging 10:387-395 (1989).
Stern, R. A. et al., "Antibodies To The .beta.-Amyloid Peptide Cross-React With Conformational Epitopes In Human Fibrinogen Subunits From Peripheral Blood," FEBS Letters 264: 43-47 (1990).
Sobel, B. E., "Intracranial Bleeding, Fibrinolysis, And Anticoagulation Causal Connections And Clinical Implications," Circulation 90:2147-2152 (1994).
Tagliavini, F. et al., "Coexistence of Alzheimer's Amyloid Precursor Protein And Amyloid Protein In Cerebral Vessel Walls," Lab. Investigation 62:761-767 (1990).
Topol, E. J. et al., "Thrombolytic Therapy For Elderly Patients," New Engl. J. Med. 327:45-47 (1992).
Torack, R. M., "Congophilic Angiopathy Complicated By Surgery And Massive Hemorrhage," Amer. J. Pathol. 81:349-366 (1982).
van Duinen, S. G. et al., "Hereditary Cerebral Hemorrhage With Amyloidosis In Patients Of Dutch Origin Is Related To Alzheimer's Disease," Proc. Natl. Acad. Sci. (U.S.A.) 84:5991-5994 (1987).
Vinters, H. V., "Cerebral Amyloid Angiopathy A Critical Review," Stroke 18:311-324 (1987).
Wijdicks, E. F. M. et al., "Intracerebral Hemorrhage After Fibrinolytic Therapy For Acute Myocardial Infarction," Stroke 24:554-557 (1993).
Yamaguchi, H. et al., "Beta Amyloid Is Focally Deposited Within The Outer Basement Membrane In The Amyloid Angiopathy Of Alzheimer's Disease," Amer. J. Pathol. 141:249-259 (1992).
Auerbach Jeffrey I.
Hartley Michael G.
Hollinden Gary E.
Rutgers The State University of New Jersey
LandOfFree
Methods for the prevention or treatment of vascular hemorrhaging does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Methods for the prevention or treatment of vascular hemorrhaging, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Methods for the prevention or treatment of vascular hemorrhaging will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-1139966